Market Research Blog – Page 1337 – New Product Development

Wearable Sleep Tracker Market Set to Reach USD 2,458.60 Million by 2034 at a 4.5% of CAGR

The wearable sleep tracker market is forecasted to achieve a valuation of USD 1,583.20 million in 2024, with substantial growth expected in the coming decade. Recent trends indicate that the market is poised to expand significantly, reaching approximately USD 2,458.60 million by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

The surge in sleep dysfunctions and disorders is a primary driver of this growth. Individuals experiencing sleep issues are increasingly turning to wearable sleep trackers to monitor their sleep patterns and identify potential triggers. The integration of advanced sleep-tracking technology into wearable devices is enhancing the adoption and functionality of these trackers, making them an essential tool for managing sleep health.

Consumers are choosing these trackers because of their increased utility and attractiveness due to the integration of cutting-edge sleep-tracking technology with wearable gadgets. The market for wearable sleep trackers is anticipated to develop significantly as these trends continue to gain popularity and become more widely accepted.

As wearable sleep trackers gain prominence and mainstream acceptance, industry stakeholders are poised to capitalize on emerging opportunities to meet the evolving needs of consumers. By leveraging advancements in sensor technology, data analytics, and user-centric design, manufacturers can enhance the accuracy, reliability, and user experience of wearable sleep tracking devices.

Market Dynamics Framing the Wearable Sleep Tracker Sector:

The rise of the wearable sleep tracking device market is being supported in large part by the rising prevalence of sleep disorders and rising disposable income. Wearable sleep trackers are expected to see significant growth in the market due to their accessibility through both online and offline distribution channels, as well as their increasing popularity as fashion items in emerging nations.

The wearable sleep tracker market is not growing as quickly as it could due to the high cost associated with smart wearable devices. The sales of wearable sleep trackers are limited by the fluctuating pricing of raw materials and the growing competition in the market.

The global wearable sleep tracker market is segmented on the basis of product type into:

Wearable Sleep Tracker Ring Devices
Wearable Sleep Tracker Wristband and Hand band Devices
Wearable Sleep Tracker Headband Devices
Wearable Sleep Mask Tracker Devices

The report begins with the market definition of wearable sleep tracker, followed by definitions of different types of wearable sleep trackers and applications for which these wearable sleep trackers are used. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global wearable sleep tracker market.

On the basis of the application, the global wearable sleep tracker market is segmented into:

Insomnia
Sleep Apnoea
Others

On the basis of the distribution channel, the global wearable sleep tracker market is segmented into:

Pharmacy and Retail Stores
Online Sales
Hypermarkets and Supermarkets
Others

Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of region, the global wearable sleep tracker market is segmented into:

North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Western Europe
- Germany
- France
- U.K.
- Spain
- Rest of Western Europe
Eastern Europe
- Russia
- Rest of Eastern Europe
Asia Pacific excluding China and Japan
- India
- Australia & New Zealand
- ASEAN
- Rest of Asia- Pacific excluding China and Japan
China
Japan
Middle East & Africa (MEA)
- South Africa
- GCC Countries
- Rest of Middle East and Africa

In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify the growth opportunities for companies operating in the global wearable sleep tracker market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by the wearable sleep tracker market. To understand the key segments in terms of their growth and performance in the global wearable sleep tracker market, Future Market Insights has developed a market attractiveness index. The resulting index will help identify the existing market opportunities in the wearable sleep tracker market.

A Old Full Report Analysis Click Here

Key Segments:

By Product:

Wearable Ring Devices
Wearable Wrist and Hand band Devices
Wearable Headband Devices
Sleep Mask Tracker Devices

By Application:

Insomnia
Sleep Apnea
Others

By End User:

Pharmacy and Retail Stores
Online Sales
Hypermarkets and Supermarkets
Others

By Region:

North America
Western Europe
Asia Pacific
Latin America
Eastern Europe
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Carpal Tunnel Release System Market Set to Reach USD 1,077.3 Million by 2034 at a 5.5% of CAGR

The global carpal tunnel release system market is projected to achieve a valuation of USD 630.7 million in 2024, with expectations of robust growth over the next decade. The market is anticipated to expand at a Compound Annual Growth Rate (CAGR) of 5.5%, reaching approximately USD 1,077.3 million by 2034.

The significant increase in carpal tunnel syndrome (CTS) prevalence, driven by underlying conditions such as diabetes, thyroid disorders, and fluid retention, is a key factor contributing to the market’s growth. As awareness of CTS and the need for effective treatment options rise, the demand for carpal tunnel release systems is expected to surge.

Market Highlights:

Current Valuation: The carpal tunnel release system market is valued at USD 630.7 million in 2024.
Future Outlook: The market is projected to grow to USD 1,077.3 million by 2034.
Growth Rate: The industry is forecasted to expand at a CAGR of 5.5% during the forecast period.

The increasing incidence of CTS and advancements in treatment technologies are driving the growth of the carpal tunnel release system market. With a focus on enhancing patient outcomes and addressing the rising prevalence of related health conditions, the market is poised for significant development.

Competition Outlook

Adoption of CRT systems and their efficacy has proven their high success rates. Manufacturers and key players are implementing advanced technology to make these machines offer better outcomes. Healthcare professionals are leveraging these systems to demonstrate their expertise and also shorten the recovery period. Leading players in the global market hold substantial shares, creating moderate competitiveness and inhibiting the presence of new entrants.

Industry Updates

In February 2024, Dartmouth Health researchers conducted groundbreaking research on amyloidosis, a life-threatening disorder. Cardiologists, orthopedic surgeons, and pathologists collaborated to identify early signs of amyloidosis, focusing on hand screening techniques during carpal tunnel release surgeries.
In February 2024, AIIMS Delhi introduced an AI tool for early cancer detection. Aster CMI Hospital developed an AI solution for Carpal Tunnel Syndrome screening, boasting 95% accuracy in diagnosis. Hospitals like Amrita in Faridabad and others embraced AI-driven pathology solutions for precise diagnosis and treatment.

A Old Full Report Analysis Click Here

Key Segments of Market Report

By Product Type:

Open CTR and endoscopic CTR are two types of products in the carpal tunnel release system industry.

By End User:

Hospitals, ambulatory surgical centers, and specialty clinics are primary end users exist in this sector.

By Region:

A regional analysis has been carried out in key countries of North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Network Management System Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

The global Network Management System (NMS) market is set to witness robust growth over the next decade, with a projected Compound Annual Growth Rate (CAGR) of 8.6% between 2022 and 2032. As per market forecasts, the market size is anticipated to surge from US$ 9.1 Billion in 2022 to an impressive US$ 21 Billion by 2032.

In today’s technologically-driven business landscape, the effective management of networks holds paramount importance, especially for enterprises operating in the IT sector. The proficient handling of networks ensures uninterrupted service delivery, seamless internal and external communication, and overall operational continuity. The upcoming wave of network management systems promises enhanced trajectory management capabilities, poised to revolutionize network operations.

The evolution of networks has been transformative due to rapid technological advancements. Network administrators now face the challenge of maintaining complex networks that consist of diverse hardware and software components, manufactured by various vendors and distributed globally. This burgeoning demand for Network Management System products that cater to the burgeoning industry needs, offering automated network management solutions, is a major driver behind the market’s growth.

Key Takeaways:

Projected CAGR of 8.6% for the Network Management System market between 2022 and 2032.
Market size estimated to grow from US$ 9.1 Billion in 2022 to US$ 21 Billion by 2032.
Evolution of networks and technological complexity drives demand for efficient NMS solutions.
Multinational corporations prioritizing secure and user-friendly network management solutions.
Small and medium-sized enterprises inclined towards on-premise NMS deployments for enhanced support.

Competitive Landscape 

BMC Software, Cisco, CA Technologies, AppNeta, Extreme Networks, Accedian, HelpSystems, Ipswitch, Kentik, Micro Focus, NETSOCUT, Nokia, Riverbed Technology, SolarWinds, VIAVI Solutions, Flowmon Networks, Paessler, Colasoft, and Cubro Network Visibility are among the major players in the network management system (NMS) market.

Global wireless communication solution providers and network equipment manufacturers are launching new network monitoring and management solutions to help operators manage their networks more efficiently.

Recent Developments

In February 2017, Ericsson unveiled as a service that assists operators in their travels to virtualization, SDN, and 5G network transformations. Nokia released the NetAct Cloud network management technology in May 2016, allowing operators to deploy new network capabilities with minimum downtime. The technology is capable of handling 5G network needs and offers total mobile network control.
In January 2017, the Chinese government lowered subsidies and relaxed laws in order to encourage more private investment in order to strengthen its internet services.
Riverbed Technology, Inc. formed a collaboration agreement with Huawei Technologies Co., Ltd in 2017 to supply Huawei CloudEPN with Riverbed SteelHead integrated solutions that may assist clients in simplifying network administration in the cloud era.

Key segments

By Component:

Platform
Solutions
Services

By Deployment Type:

Cloud
On-Premises

By Organisational Size:

Large Enterprise
Small & Medium Sized Enterprise

By End Use:

Service Providers
Verticals

By Region:

North America
Latin America
Europe
APAC
Middle East & Africa

Don’t Miss Out on Expertise: Grab Your Copy of the Report Now!

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Analgesics Market Poised to Reach USD 143.65 Billion by 2034, With a CAGR of 4.6%

The global analgesics market is set to achieve a revenue of USD 91.62 billion in 2024, reflecting a steady increase in its share within the drugs and medication sector. According to recent market forecasts, the industry is expected to grow at a robust Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period, culminating in a projected valuation of approximately USD 143.65 billion by 2034.

The rising prevalence of chronic pain conditions and the continuous advancements in pain management therapies are driving this growth. As the demand for effective pain relief solutions escalates, the analgesics market is witnessing an upward trend, underscoring its expanding role in the pharmaceutical industry.

Market Highlights:

Current Valuation: The analgesics market is forecasted to generate revenue of US$ 91.62 billion in 2024.
Future Outlook: The market is anticipated to reach a valuation of about US$ 143.65 billion by 2034.
Growth Rate: The industry is projected to grow at a CAGR of 4.6% throughout the forecast period.

The continued innovation in analgesic formulations and increased focus on addressing diverse pain management needs are key factors contributing to the market’s promising trajectory. The sector’s growth reflects the ongoing efforts to enhance patient care and develop more effective pain relief options.

Competitive Landscape for Analgesics Market

Key players are focusing on novel and innovative approaches for the development of non-opioid or non-addictive formulations for pain management. Leading companies are strengthening their product portfolio and global footprint through acquisitions.

The strategy of expansion, new product launches, and approvals by key manufacturers is further strengthening their market presence. Besides these, mergers and acquisitions have emerged as key growth strategies adopted by market players.

Recent Developments in the Global Analgesics Market

ZYNRELEF was launched in July 2021 by Heron Therapeutics Inc., based in the United States. Designed to provide postsurgical analgesia for up to 72 hours after a bunionectomy, inguinal herniorrhaphy, or total knee replacement, it is an extended-release product for soft tissue or periarticular application.
In October 2017, Pfizer Inc., and other leading healthcare organizations AmerisourceBergen, Blue Cross Blue Shield Association, and Prime Therapeutics joined Walgreens (the United States’ largest drugstore chain) to combat the national opioid abuse crisis by expanding the availability of safe medication disposal kiosks to an additional 900 Walgreens stores.
In May 2020, Assertio Therapeutics, Inc., based in California, merged with Zyla Life Sciences, based in Pennsylvania. The merger created a growing commercial pharmaceutical company with neurology, inflammation, and pain products.

A Old Full Report Analysis Click Here

Key Segments Covered by Analgesics Industry Survey Report

By Drug Class:

Opioids
NSAIDs
Local Anesthetics
Acetaminophen

By Indication:

Surgical Pain
Cancer Pain
Neuropathic Pain

By Route of Administration:

Oral
Parenteral
Transdermal

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Store
Clinics
Other Sales Channels

By Region:

North America
Latin America
Europe
East Asia
South Asia and Pacific
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Intellectual Property Software Market Set for Rapid Growth with 12.7% CAGR, Projected to Reach $14.9 Billion by 2032

According to a new analysis from FMI, the market for intellectual property software is anticipated to grow at a rate of 12.7% over the course of the projection year and reach US$ 14.9 billion by 2032. By 2022, the intellectual property software industry is expected to be worth US$ 4.5 billion. The research claims that the possible harm that unlicensed public usage may bring to a company’s whole business strategy and financial performance is the reason for the rising need for intellectual property software.

Sales of software related to intellectual property are expected to rise significantly. Furthermore, it is anticipated that by 2026, software with intellectual property protection would sell for US$ 7.7 billion more.Increasing sales of intellectual property software are also projected to contribute to the growth of the intellectual property software market share.

To gain a competitive advantage, effective intellectual property software tools are required in the market. Companies are being influenced by the extremely competitive business climate to invest in technology that ensures businesses and sales of intellectual property software policies are strictly matched to ensure the smooth operation of the organisation.

Enterprise management of intellectual property software is gaining popularity throughout the world as businesses realise that unauthorised public use can harm not just the company’s overall bottom line but also its whole business strategy.

The intellectual property software industry is growing due to an increase in application and understanding of intellectual property rights among end-users. The expansion in the intellectual property software industry is fueled by an increase in demand for a secure and well-documented system inside a company.

However, problems such as the difficulty of maintaining software and the high cost of investment, as well as a low rate of awareness and data security, are impeding the intellectual property software market growth.

Furthermore, advancements in information and communication technology, as well as increased awareness and acceptance of intellectual property software in emerging nations like India, are expected to provide significant market potential.

Component, deployment, end-user, application, and geography are all used to segment the intellectual property software industry. The market is divided into two components: software and service. The market is divided into cloud and on-premise deployment modes. The market is divided into two types of end-users: individual and commercial. BFSI, IT and telecom, automotive, education, retail and agriculture, healthcare, and others are sub-segments of the commercial segment. The intellectual property software industry is divided into patent management, trade management, licensing, and other applications. It is divided into four regions: North America, Europe, Asia Pacific, Latin America, and the Caribbean.

Manufacturers in the intellectual property software market get a big platform from which to serve the whole demand for intellectual property software. The worldwide sales of intellectual property software are seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for intellectual property software more accessible to customers.

Key Takeaways:

The worldwide corporate intellectual property software market is growing as companies place a greater emphasis on safeguarding and managing their intellectual property portfolios.
As more companies focus on tactically organising their intellectual property software assets and safeguarding them from unlicensed use, corporate intellectual property software is gaining appeal.
Furthermore, frequent product customization by end-users benefits the enterprise intellectual property management software market, as it protects and safeguards the most important aspects of intellectual property software and treatment, such as inventions, patents, trademarks, and other intellectual property software contracts, in a systematic manner.
However, despite all of the benefits, these service providers face a number of hurdles and impediments in the early phases, the majority of which are related to the high cost of establishing services in an organisation.
During the forecast period, 2016–2026, the worldwide enterprise intellectual property management software market is expected to develop at a healthy rate.

Competitive Landscape

Anaqua, Inc., Patrix AB, IPfolio, SimpleLegal, Pattsy, FlexTrac, Lecorpio, WebTMS, and CPA Worldwide are some of the prominent players in the global intellectual property management software industry (Patrafee).

To cope with infringement, China’s central government has created a specialist intellectual property software section in courts, and it is devoted to simplifying trademark enforcement operations. In addition, India is developing a digital infrastructure in accordance with its national IP strategy. This strategy will preserve intellectual property software while also safeguarding and promoting patents.
CPA Global unveiled its customer-centric approach in November 2019 to improve intellectual property software outcomes through better data-enabled intellectual property software decision-making and increased intellectual property software productivity throughout the sector. CPA Global now operates in two major business divisions: Software and Tech-Enabled Services, after the purchase of ipan/Delegate Group.

Buy Complete Report:

Key Segments

By Component:

Software
- Cloud-based
- On Premise
Services
- Development & Implementation Services
- Consulting Services
- Maintenance & Support Services

By Application:

Patent Management
Trademark Management
Intellectual Property (IP) Portfolio Management
Intellectual Property (IP) Licensing
Intellectual Property (IP) Reporting & Analytics
Others

By End-use:

Individuals (independent Inventors)
Enterprises

By Region:

North America
Europe
Asia Pacific
Middle East and Africa
South America

About Future Market Insights (FMI)

Contact Us:

Peripheral Vascular Stent Market Set to Surge to USD 8,878.00 million by 2034 at a 7.60% of CAGR

According to the latest research report by Future Market Insights (FMI), the global peripheral vascular stent market is anticipated to reach a valuation of USD 4,267.70 million in 2024. The market is projected to experience significant growth, expanding at a robust Compound Annual Growth Rate (CAGR) of 7.60% over the next decade.

The surge in the peripheral vascular stent market is largely attributed to ongoing innovations in stent designs and materials, which enhance their effectiveness in medical procedures. Manufacturers are actively expanding their market presence by introducing advanced peripheral vascular stents, responding to the increasing demand driven by a rise in peripheral artery disease (PAD) and the need for improved treatment solutions.

According to revenue analysis of the peripheral vascular stent market by FMI analysts for the year 2034, the market is expected to surpass USD 8,878.00 million.

Peripheral Artery Disease and Aging Population Drive Demand

The increasing prevalence of PAD, a condition that affects blood flow in the arteries of the legs and arms, is a significant driver of market growth. As the population ages, the risk of PAD also increases, leading to a greater demand for peripheral vascular stents as a treatment option.

Minimally Invasive Procedures Gaining Traction

The growing adoption of minimally invasive procedures for peripheral vascular interventions is another factor contributing to market expansion. These procedures offer patients faster recovery times and less discomfort compared to traditional open surgery. Peripheral vascular stents play a crucial role in these minimally invasive techniques.

Global Peripheral Vascular Stents Market: Segmental Forecast

The global peripheral vascular stents market has been segmented on the basis of product type, artery type, end user and regions. Globally, the self-expanding stents is expected to be the most attractive segment from the manufacturers’ point of view. Although there is a high demand for drug eluting stents and the segment leads in terms of market volume in the forecast period, high price of drug eluting stents would lead to low revenue contribution of the product type segment. Among all the artery types, high demand of peripheral stents is expected to come from iliac artery segment due to growing prevalence for peripheral artery disease in many countries across the globe.

Global Peripheral Vascular Stents Market: Regional Analysis

In terms of value, the global peripheral vascular stents market is expected to expand at 6% CAGR over the forecast period of 2022–2028. With nearly 48.5% market share, North America dominated in the global peripheral vascular stents market in 2021, partly due to penetration of newly approved drug eluting stents in the U.S. Western Europe is expected to be the second large market globally, with the U.K., Italy, France and Germany being countries with high growth rates. APEJ is expected to be the second large market for peripheral vascular stents, primarily due to improving immunization access and availability of cost-effective surgeries.

Global Peripheral Vascular Stents Market: Competition Tracking

The market for peripheral vascular stents is consolidated with few players contributing over 55% of revenue share. The key players identified in the global market include Medtronic Plc., Becton, Dickinson and Company, Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., and Cook Medical Inc., among others. Acquisition of established products to gain immediate growth is the key strategy adopted by key players in the market.

Key Companies Profiled:

Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
MicroPort Scientific Corporation
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
Abbott Laboratories
W.L. Gore & Associates Inc.
Cook Medical Inc.

A Old Full Report Analysis Click Here

Market Segmentation:

Peripheral Vascular Stents Market by Product Type:

Self-Expanding Stents
Balloon-Expanding Stents
Covered Stents
Drug-Eluting Stents

Peripheral Vascular Stents Market by Artery Type:

Carotid Artery
Fem-Pop Artery
Iliac Artery
Infrapop Artery

Peripheral Vascular Stents Market by End User:

Hospitals
Ambulatory Surgical Centers/Outpatients

Peripheral Vascular Stents Market by Region:

North America Peripheral Vascular Stents Market
Latin America Peripheral Vascular Stents Market
Europe Peripheral Vascular Stents Market
East Asia Peripheral Vascular Stents Market
South Asia & Pacific Peripheral Vascular Stents Market
Middle East & Africa (MEA) Peripheral Vascular Stents Market

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Accounting Software Market to Grow from USD 8.0 Billion in 2022 to USD 14.1 Billion by 2032, at a 5.8% CAGR: FMI Report

According to a recent report by Future Market Insights (FMI), the market for accounting software is expected to reach a valuation of US$ 14.1 billion in 2032, growing at a compound annual growth rate (CAGR) of about 5.8%. The market is anticipated to reach US$ 8.0 billion by the end of 2022.

The software category is composed of the commercial off-the-shelf, enterprise accounting, custom accounting, reconciliation, and tax management software divisions. The firm accounting software market is predicted to develop at a 6.8% annual pace and reach US$ 5.2 billion in value by 2032.

Many businesses are using enterprise accounting software because it allows the board to conduct corporate operations in a single system. ERP is a well-known subset of well-known software, and an ERP system is made up of several modules that each clearly address certain business goals.

Several organizations have been implementing enterprise accounting software since they assist with carrying out resource management and coordinate all business activities in a single system. ERP is a prominent section of enterprise software, and an ERP system comprises different modules that address explicit business needs.

ERP system does not require a wide range of tools to handle the various needs of different departments, as it has an integrated solution multiple tasks can foresee in a single platform.

As enterprise business grows, the need of automating complex data and as the reporting strategies will increase and the monitoring of assets is very much required, and in these scenarios, enterprise accounting software is prominently useful. The accounting and fund management capacities and abilities intrinsic in ERP arrangements give real-time information to the departments which boost decision-making effectively.

Key Takeaways from the Accounting Software Market Study

Enterprise accounting software is expected to hold the largest share in the component segment and is expected to grow at a CAGR of 6.8% in forecast period.
The market in the U.S. is projected to account for a CAGR 7.0% from 2022 to 2032.
Software as a Service is expected to emerge as the fastest-growing segment with market value of US$ 9.2 Bn in 2032 and registering a CAGR of 6.8% from 2022 to 2032.

“Global revenue through the offices of certified public accountants is expected to swell by US$ 1 Bn between 2022 and 2024; carrying enormous opportunity for accounting software market”opines Sudip Saha, managing director at Future Market Insights (FMI) analyst.

Who is winning?

Leading players of Accounting Software Market are focused in implementing for tracking and recording the fund inflow and outflow. Previously, accounts were managed manually and recorded every transaction in a physical book called ledgers. Accounting software replaces these records and permits the organization to record their fund transactions with the software.

Major players present in the Accounting Software Market industry are Infor, Microsoft Corporation, MRI Software, LLC, Oracle, Sage, SAP SE, Workday, Zeta Global among others.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global Accounting Software Market, presenting historical demand data (2016-2021) and forecast statistics for the period from 2022 to 2032.

The study divulges compelling insights on the Accounting Software Market based on Deployment (Software as a Service, On-Premise, Hybrid) Software Type (Commercial of the Shelf, Enterprise Accounting Software, Custom Accounting Software, Reconciliation, Tax Management) Application (Payroll Management Systems, Billing & Invoice System, Enterprise Resource Planning Systems, Time & Expense Management Systems, Others(Recurring Billing Software, Small)) Enterprise Size (Large Enterprise, Small and Medium Enterprise) Industry (Banking Financial Services and Insurance, Telecom and Information and Technology, Manufacturing, Construction, Wholesale Distribution, Non-Profit Organization, Chemicals, Food and Beverage, Others) across five major regions.

Global Accounting Software Market by Category

By Deployment:

Software as a Service (SaaS)
On-Premise
Hybrid

By Software Type:

Commercial of the Shelf
Enterprise Accounting Software (ERP)
Custom Accounting Software
Reconciliation
Tax Management

By Application:

Payroll Management Systems
Billing & Invoice System
Enterprise Resource Planning Systems
Time & Expense Management Systems
Others(Recurring Billing Software, Small)

By Enterprise Size:

Large Enterprise
Small and Medium Enterprise

By Industry:

Banking Financial Services and Insurance
Telecom and Information and Technology
Manufacturing
Construction
Wholesale Distribution
Non-Profit Organization
Chemicals
Food and Beverage
Others

By Region:

North America
Latin America
Europe
Asia Pacific
MEA

Click to Buy Your Exclusive Report Immediately!

About Future Market Insights (FMI)

Contact Us:

Amniotic Membrane Market Projected to Reach USD 2,279.5 Million by 2034, With a Robust CAGR of 4.2%

The amniotic membrane market is set for substantial growth, with an estimated valuation of USD 1,510.6 million in 2024. According to recent forecasts, the market is expected to exceed USD 2,279.5 million by 2034, reflecting a steady Compound Annual Growth Rate (CAGR) of 4.2% over the forecast period.

The increasing demand for amniotic membranes is driven by their significant therapeutic potential across various medical fields, including wound healing, ophthalmology, and tissue regeneration. These membranes are valued for their unique properties, which support rapid tissue repair and regeneration, making them a vital component in advanced medical treatments.

The population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic about increasing amniotic membrane transplants and increasing demand for amniotic membrane products worldwide, particularly in North American countries. It is more than likely that over the next four to five years, the companies focus on developing innovative products and designing market-level strategies to leverage the potential opportunities emerging in parallel with the growing human population with various chronic diseases.

Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membranes and lyophilized amniotic membranes evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.

The global amniotic membrane market has been segmented based on product type, application, end-user and region. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory properties. Among all end users of amniotic membranes, high demand for amniotic membranes is expected to come from the hospital segment due to the rising application of amniotic membranes in advanced surgical healing.

By volume

The global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to the penetration of newly approved products in the U.S. Western Europe, the second largest market globally, with the U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third-largest market for amniotic membranes. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.

The market for amniotic membranes is highly consolidated with the top 5 players contributing over 60% of the revenue share in 2017.

Examples of some of the key players identified in the Amniotic Membrane Market are Integra

LifeSciencesm Inc.
MiMedx Group, Inc.
Alliqua BioMedical, Inc.
Skye Biologics Inc.
Katena Products, Inc.
Tissue-Tech Inc.
Amnio Technology, LLC
Applied Biologics LLC
Human Regenerative Technologies, LLC

Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market

Some of the key points identified in the Amniotic Membrane Market are:

Market Valuation: The global amniotic membrane market is estimated to be US$ 1,510.6 million in 2024.
Future Projections: By 2034, the market is forecasted to exceed a valuation of US$ 2,279.5 million, recording a CAGR of 4.2%.
Therapeutic Potential: Amniotic membrane demand is primarily fueled by its therapeutic potential, particularly in wound healing, ophthalmology, and tissue regeneration.

Key Segments of Amniotic Membrane Market Survey

by Product Type:

Cryopreserved Amniotic Membranes
Lyophilized Amniotic Membranes

by Application:

Surgical Wounds
Ophthalmology
Others

by End User:

Amniotic Membrane Treatment in Hospitals
Amniotic Membrane Treatment in Specialized Clinics
Amniotic Membrane Treatment in Ambulatory Surgical Centres
Amniotic Membrane Treatment in Academic Research Centres

by Region:

North America Amniotic Membranes Market
Latin America Amniotic Membranes Industry
Europe Amniotic Membranes Market
East Asia Amniotic Membranes Industry
South Asia & Pacific Amniotic Membranes Market
Middle East & Africa (MEA) Amniotic Membranes Industry

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

5G Security Market to Skyrocket: Projected Growth from $1.2 Billion in 2022 to $12.5 Billion by 2032

The global 5G security market, valued at US$ 1.2 Billion in 2022, is set to experience remarkable growth, reaching an estimated US$ 12.5 Billion by the year 2032. These findings emerge from a comprehensive research study conducted by Future Market Insights, showcasing a robust Compound Annual Growth Rate (CAGR) of 26.4% spanning the years 2022 to 2032.

Solutions include the equipment required to guarantee safety. Some tools that are utilised to provide 5G security include next-generation firewalls, data loss prevention, antivirus/antimalware, DDoS protection, security gateways, and sandboxing.

DLP instruments help to design data loss prevention methodologies by giving pre-portrayed approach controls to follow the advancement of data. It also hinders unapproved sharing, corrupting, as well as pull of data. The data loss is mainly done via malware attack and taking control of the system. According to Verizon’s 2021 Data Breach Investigations Report, malware was involved in nearly 15% of data breach. To reduce the malware attacks and security breaches companies are focussed in 5G technology.

With the growing concern of consumers worldwide regarding their health and their growing annual healthcare budget, healthcare stakeholders are becoming richer every day. But, at the same time with the evolution of new technologies and their need for speed and automation have made them vulnerable to cyber threats.

5G capabilities have added numerous advantages to healthcare sector including speed, capacity, hyper-connectivity, low latency, and data-driven insights. The higher speed and lower latency offered by 5G can be a boon to the cyber attackers as it offers them opportunity to access more data due to hyper-connectivity.

Key Takeaways from the 5G Security Market Study

5G Non-standalone is expected to hold the largest share in the architecture segment and is expected to grow at a CAGR of 24.9% in forecast period.
The U.S. holds a growth of CAGR 25.9% from 2022 to 2032.
The solutions segment is expected to emerge as the fastest-growing segment, registering a CAGR of 25.8% from 2022 to 2032.

Drivers and Opportunities

The market’s unprecedented growth is driven by the convergence of technological innovation and pressing security concerns. The widespread adoption of 5G technology across industries amplifies the need for comprehensive security solutions, propelling market expansion. Additionally, the rise of the Internet of Things (IoT) and the proliferation of connected devices create a conducive environment for the 5G security market to flourish.

Competition Analysis

The 5G security landscape is characterized by a competitive market space featuring prominent players committed to offering state-of-the-art security solutions. Industry leaders are investing in research and development to deliver cutting-edge products that safeguard against emerging threats, while also focusing on strategic collaborations to consolidate their market presence.

Regional Trends

The growth of the 5G security market is not confined to a specific region; it exhibits a global trend. North America, Europe, Asia-Pacific, and other regions are witnessing substantial investments in 5G infrastructure, thus driving the demand for effective security measures to protect these critical networks.

Global 5G Security Market by Category

By Component:

Solutions
- Next-Generation Firewall
- Data Loss Prevention
- Antivirus/Antimalware
- DDoS Protection
- Security Gateway
- Sandboxing
- Others
Services
- Consulting Services
- Implementation Services
- Support and Maintenance Services

By Network Component Security:

RAN Security
Core Security

By Architecture:

5G NR Non-standalone
5G NR Standalone

By End User:

Telecom Operators
Enterprises

By Deployment Type:

Cloud
On-Premises

By Vertical:

Manufacturing
Healthcare
Energy and Utilities
Retail
Automotive and Transportation
Public Safety
Media and Entertainment
Others

By Region:

North America
Latin America
Europe
Asia Pacific
MEA

Drive Success with Data: Purchase Your Copy of the Report Here

About Future Market Insights (FMI)

Contact Us:

Enzyme Replacement Therapy Market Set to Reach USD 20,289.1 Million by 2034 at a 6.60% of CAGR

Recent medical studies reveal that one in every seven thousand childbirths is affected by lysosomal storage diseases, a statistic that is rising, particularly in underdeveloped countries with limited awareness and medical resources. This growing prevalence is significantly contributing to the expansion of the enzyme replacement therapy market, which is expected to be valued at an impressive USD 10,707.6 million by 2024.

Enzyme replacement therapy is crucial for treating rare diseases such as Gaucher disease and Fabry disease. Advances in medical technology and the increasing availability of sophisticated healthcare facilities, both public and private, are further propelling the market’s growth. The enzyme replacement therapy market is anticipated to expand at a healthy Compound Annual Growth Rate (CAGR) of 6.60% from 2024 to 2034.

Government initiatives to increase public awareness and lenient reimbursement policies are also driving market growth. By the end of the forecast period, the market is projected to reach a valuation of USD 20,289.1 million.

Enzyme Replacement Therapy Industry: Regional Insights

With nearly 25%-30% market share, North America dominated the Global Enzyme Replacement Therapy Industry in 2017, partly due to the presence of leading market players in the region. In developing regions such as Latin America, advancements in medical facilities are helping the region cope with the healthcare crisis. Medical facilities in Brazil are equivalent to hospitals in the United States, with some even exceeding American standards. Brazil offers everything from large, full-service hospitals to smaller, intimate private clinics.

Brazil has developed into a center of excellence for healthcare in Latin America, with major universities that support the research, teaching, and training of medical professionals. Western Europe is the second largest market globally and is expected to be valued at US$ 2,893.2 Mn by 2028, with France, Italy, and Spain projected to witness significant growth rates. Japan is expected to be the third largest market for enzyme replacement therapy.

Enzyme Replacement Therapy Market: Segmentation & Forecast

The Global Enzyme Replacement Therapy Industry has been segmented based on therapeutic condition, route of administration, distribution channel, and region. Therapeutic conditions in the enzyme replacement therapy markets include Fabry disease, Gaucher disease, mucopolysaccharidosis, Pompe disease, lysosomal acid lipase deficiency, and others.

Globally, the mucopolysaccharidosis therapeutic condition is the most attractive segment. The injectable segment remains the most lucrative route of administration in the Global Enzyme Replacement Therapy Industry. Among all distribution channels for enzyme replacement therapy, specialty treatment pharmacies are expected to be the most lucrative, followed by hospital pharmacies.

Key Research Findings

Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of US$ 6,448.3 Mn between 2022 and 2028

When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.

Enzyme Replacement Therapy Market: Competitive Landscape

Sanofi S.A. (Genzyme Corporation)
Shire plc.
Pfizer Inc.
Alexion Pharmaceuticals Inc.
BioMarin Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Johnson & Johnson Services Inc.
Allergan plc.
Leadiant Biosciences Inc.

Pompe Disease Treatment Market Is a type of treatment for certain genetic diseases that are caused by a deficiency in a specific enzyme. This therapy involves administering the missing enzyme to the patient, usually through intravenous infusion.

A Old Full Report Analysis Click Here

Key Segments of Enzyme Replacement Therapy Industry Survey

by Therapeutic Condition:

Enzyme Replacement Therapy for Fabry Disease
Enzyme Replacement Therapy for Gaucher Disease
Enzyme Replacement Therapy for Mucopolysaccharidosis
- MPS I
- MPS II (Hunter Syndrome)
- MPS IVA (Morquio Syndrome, Type A)
- MPS VI (Maroteaux-Lamy Syndrome)
- MPS VII (Sly Syndrome)
Enzyme Replacement Therapy for Pompe Disease
Enzyme Replacement Therapy for Lysosomal Acid Lipase Deficiency
Others

by Route of Administration:

Oral Enzyme Replacement Therapy
Injectable Enzyme Replacement Therapy

by Distribution Channel:

Hospital Pharmacies
Specialty Treatment Pharmacies
Retail Pharmacies

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: